Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A14281 | 29484808 | Diabetes Obes Metab | Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial. | 2018 | Details |
| A14282 | 29484189 | Pharmacol Res Perspect | Race affects SVR12 in a large and ethnically diverse hepatitis C-infected patient population following treatment with direct-acting antivirals: Analysis of a single-center Department of Veterans Affairs cohort. | 2018 | Details |
| A14283 | 29483677 | J Hum Genet | Could inherited predisposition drive non-obese fatty liver disease? Results from German tertiary referral centers. | 2018 | Details |
| A14284 | 29483581 | Sci Rep | Quantitative Assessment of Liver Steatosis and Affected Pathways with Molecular Imaging and Proteomic Profiling. | 2018 | Details |
| A14285 | 29483369 | Biosci Rep | Maternal obesity increases the risk of metabolic disease and impacts renal health in offspring. | 2018 | Details |
| A14286 | 29482963 | Nutr Metab Cardiovasc Dis | Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study. | 2017 | Details |
| A14287 | 29482933 | Acta Histochem | Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study. | 2018 | Details |
| A14288 | 29482168 | Redox Biol | Fasting exacerbates hepatic growth differentiation factor 15 to promote fatty acid β-oxidation and ketogenesis via activating XBP1 signaling in liver. | 2018 | Details |
| A14289 | 29481986 | J Nutr Biochem | Replacement of soybean oil by fish oil increases cytosolic lipases activities in liver and adipose tissue from rats fed a high-carbohydrate diets. | 2018 | Details |
| A14290 | 29481310 | FASEB J | Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice. | 2018 | Details |
| A14291 | 29480487 | Methods Mol Biol | Measurement of AMPK-Induced Inhibition of Lipid Synthesis Flux in Cultured Cells. | 2018 | Details |
| A14292 | 29479832 | Liver Int | Osteoporosis in chronic liver disease. | 2018 | Details |
| A14293 | 29479443 | Gastroenterol Rep (Oxf) | Effects of lifestyle modification on liver enzyme and Fibroscan in Indian patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A14295 | 29477657 | Eur J Pharmacol | Berberine induces miR-373 expression in hepatocytes to inactivate hepatic steatosis associated AKT-S6 kinase pathway. | 2018 | Details |
| A14296 | 29477355 | Endocrinol Diabetes Nutr (Engl Ed) | Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes. | 2018 | Details |
| A14298 | 29476945 | Ultrasonics | Ultrasound parametric imaging of hepatic steatosis using the homodyned-K distribution: An animal study. | 2018 | Details |
| A14299 | 29475944 | J Biol Chem | Hepatic loss of Lissencephaly 1 (Lis1) induces fatty liver and accelerates liver tumorigenesis in mice. | 2018 | Details |
| A14301 | 29474931 | Biochim Biophys Acta Mol Cell Biol Lipids | Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model. | 2018 | Details |
| A14302 | 29473277 | Hepatol Res | Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease. | 2018 | Details |
| A14303 | 29472712 | Nat Rev Endocrinol | Direct effects of thyroid hormones on hepatic lipid metabolism. | 2018 | Details |
| A14304 | 29472495 | Drug Metab Dispos | Apixaban and Rosuvas--tatin Pharmacokinetics in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14305 | 29225776 | F1000Res | The sedentary (r)evolution: Have we lost our metabolic flexibility? | 2017 | Details |
| A14306 | 29471595 | Diabetes Metab Res Rev | Procollagen-III peptide identifies adipose tissue-associated inflammation in type 2 diabetes with or without nonalcoholic liver disease. | 2018 | Details |
| A14307 | 29471562 | Semin Liver Dis | Can Elastography Differentiate Isolated Fatty Liver from Nonalcoholic Steatohepatitis? | 2018 | Details |
| A14308 | 29471561 | Semin Liver Dis | Nonalcoholic Fatty Liver Disease in Children. | 2018 | Details |
| A14309 | 29471012 | J Hepatol | Paediatric fatty liver disease (PeFLD): All is not NAFLD - Pathophysiological insights and approach to management. | 2018 | Details |
| A14310 | 29470816 | J Physiol Biochem | Hepatic subcellular distribution of squalene changes according to the experimental setting. | 2018 | Details |
| A14311 | 29470354 | Transplantation | Poor Survival After Retransplantation in NASH Cirrhosis. | 2019 | Details |
| A14312 | 29470286 | J Pediatr Gastroenterol Nutr | Genetic Variants Associated With Obesity and Insulin Resistance in Hispanic Boys With Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14317 | 29469051 | Ann Hepatol | Nonalcoholic Fatty Liver Disease Progresses into Severe NASH when Physiological Mechanisms of Tissue Homeostasis Collapse. | 2018 | Details |
| A14318 | 29469042 | Ann Hepatol | More Evidence for the Genetic Susceptibility of Mexican Population to Nonalcoholic Fatty Liver Disease through PNPLA3. | 2018 | Details |
| A14319 | 29469041 | Ann Hepatol | Natural Extracts Abolished Lipid Accumulation in Cells Harbouring non-favourable PNPLA3 genotype. | 2018 | Details |
| A14320 | 29467378 | Sci Rep | InForm software: a semi-automated research tool to identify presumptive human hepatic progenitor cells, and other histological features of pathological significance. | 2018 | Details |
| A14321 | 29466845 | Korean J Intern Med | Duodenal Niemann-Pick C1-like 1 expression was negatively correlated with liver X receptor expression in nonalcoholic fatty liver disease. | 2018 | Details |
| A14322 | 29466788 | Cell Physiol Biochem | Metformin-Induced Changes of the Coding Transcriptome and Non-Coding RNAs in the Livers of Non-Alcoholic Fatty Liver Disease Mice. | 2018 | Details |
| A14323 | 29466466 | PLoS One | Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach. | 2018 | Details |
| A14325 | 29464180 | Int J Genomics | Lingguizhugan Decoction Protects against High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease by Alleviating Oxidative Stress and Activating Cholesterol Secretion. | 2017 | Details |
| A14326 | 29464178 | Can J Gastroenterol Hepatol | Diagnostic Accuracy of Platelet Count and Platelet Indices in Noninvasive Assessment of Fibrosis in Nonalcoholic Fatty Liver Disease Patients. | 2017 | Details |
| A14327 | 29463916 | Int J Obes (Lond) | Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity. | 2018 | Details |
| A14328 | 29463906 | Nat Rev Gastroenterol Hepatol | Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD. | 2018 | Details |
| A14329 | 29463471 | EBioMedicine | IL-4 Receptor Alpha Signaling through Macrophages Differentially Regulates Liver Fibrosis Progression and Reversal. | 2018 | Details |
| A14330 | 29463133 | Arch Physiol Biochem | Effects of combined therapy with resveratrol, continuous and interval exercises on apoptosis, oxidative stress, and inflammatory biomarkers in the liver of old rats with non-alcoholic fatty liver disease. | 2018 | Details |
| A14331 | 29463026 | Nutrients | The Nile Rat (Arvicanthis niloticus) as a Superior Carbohydrate-Sensitive Model for Type 2 Diabetes Mellitus (T2DM). | 2018 | Details |
| A14332 | 29463024 | Int J Mol Sci | Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH. | 2018 | Details |
| A14333 | 29462898 | Diseases | Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease? | 2018 | Details |
| A14334 | 29462566 | Am J Physiol Endocrinol Metab | Nonalcoholic fatty liver disease and gastric bypass surgery regulate serum and hepatic levels of pyruvate kinase isoenzyme M2. | 2018 | Details |
| A14335 | 29462565 | Am J Physiol Endocrinol Metab | Pycnogenol protects against diet-induced hepatic steatosis in apolipoprotein-E-deficient mice. | 2018 | Details |
| A14336 | 29461924 | J Biopharm Stat | Controlling alpha for mixed effects models for repeated measures. | 2018 | Details |
| A14337 | 29461236 | Georgian Med News | FEATURES OF EXCRETION OF MELATONIN IN URINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND NON-ALCOHOLIC FATTY LIVER DISEASE WITH MANIFESTATIONS OF FIBROSIS AND ITS RELATIONSHIP WITH CERTAIN METABOLIC AND IMMUNOLOGICAL INDICATORS. | 2018 | Details |
| A14338 | 29459774 | Sci Rep | Nonylphenol aggravates non-alcoholic fatty liver disease in high sucrose-high fat diet-treated rats. | 2018 | Details |
| A14339 | 29457838 | Hepatology | Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in mice. | 2018 | Details |
| A14340 | 29456698 | Exp Ther Med | Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus. | 2018 | Details |
| A14341 | 29456675 | Exp Ther Med | Correlation between PPAR-α methylation level in peripheral blood and atherosclerosis of NAFLD patients with DM. | 2018 | Details |
| A14342 | 29456458 | Proteome Sci | Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease. | 2018 | Details |
| A14343 | 29456073 | Cell Metab | An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans. | 2018 | Details |
| A14344 | 29454969 | Biochem Biophys Res Commun | JIP3 knockout protects mice against high fat diet-induced liver injury. | 2018 | Details |
| A14345 | 29454967 | Biochem Biophys Res Commun | SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation. | 2018 | Details |
| A14346 | 29454647 | Cell Immunol | Dynamic plasticity of macrophage functions in diseased liver. | 2017 | Details |
| A14347 | 29453464 | Int J Obes (Lond) | Dietitian-led lifestyle modification programme for obese Chinese adolescents with non-alcoholic fatty liver disease: a randomized controlled study. | 2018 | Details |
| A14349 | 29452601 | Cardiovasc Diabetol | Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. | 2018 | Details |
| A14350 | 29452268 | Clin Gastroenterol Hepatol | High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study. | 2018 | Details |
| A14351 | 29452209 | J Hepatol | Prolactin improves hepatic steatosis via CD36 pathway. | 2018 | Details |
| A14352 | 29452135 | Prog Cardiovasc Dis | Evidence-Based Exercise Recommendations to Reduce Hepatic Fat Content in Youth- a Systematic Review and Meta-Analysis. | 2018 | Details |
| A14355 | 29451179 | Saudi J Gastroenterol | Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis. | 2018 | Details |
| A14356 | 29450671 | Inflammopharmacology | Short-term treatment with metformin reduces hepatic lipid accumulation but induces liver inflammation in obese mice. | 2018 | Details |
| A14357 | 29450605 | Abdom Radiol (NY) | Abbreviated mpMRI protocol for diffuse liver disease: a practical approach for evaluation and follow-up of NAFLD. | 2018 | Details |
| A14358 | 29450137 | Biochim Open | Liver and Metformin: Lessons of a fructose diet in mice. | 2017 | Details |
| A14359 | 29449533 | Cell Death Dis | Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2. | 2018 | Details |
| A14360 | 29448843 | Expert Opin Investig Drugs | Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis. | 2018 | Details |
| A14361 | 29447962 | Int J Biol Macromol | Low molecular weight fucoidan attenuates liver injury via SIRT1/AMPK/PGC1α axis in db/db mice. | 2018 | Details |
| A14362 | 29446942 | J Med Chem | Design, Synthesis, and Evaluation of a Novel Series of Indole Sulfonamide Peroxisome Proliferator Activated Receptor (PPAR) α/γ/δ Triple Activators: Discovery of Lanifibranor, a New Antifibrotic Clinical Candidate. | 2018 | Details |
| A14363 | 29446839 | Lipids | Siphonaxanthin, a Carotenoid From Green Algae, Inhibits Lipogenesis in Hepatocytes via the Suppression of Liver X Receptor α Activity. | 2018 | Details |
| A14364 | 29446106 | Aliment Pharmacol Ther | Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement. | 2018 | Details |
| A14365 | 29445657 | Med J Islam Repub Iran | Correlation of visfatin level with non-alcoholic fatty liver in metabolic syndrome. | 2017 | Details |
| A14366 | 29445363 | Front Microbiol | Helicobacter pylori Infection Is Not Associated with Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study in China. | 2018 | Details |
| A14370 | 29441440 | Front Med | γδ T cells in liver diseases. | 2018 | Details |
| A14371 | 29441342 | Can J Gastroenterol Hepatol | Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre. | 2017 | Details |
| A14372 | 29441049 | Front Microbiol | Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A14373 | 29441019 | Front Pharmacol | Natural Medicines Used in the Traditional Tibetan Medical System for the Treatment of Liver Diseases. | 2018 | Details |
| A14374 | 29439143 | Biosci Rep | Anarchy in the UPR: A Ca2+-insensitive PKC inhibits SERCA activity to promote ER stress. | 2018 | Details |
| A14375 | 29438776 | Food Chem Toxicol | Quercetin ameliorates HFD-induced NAFLD by promoting hepatic VLDL assembly and lipophagy via the IRE1a/XBP1s pathway. | 2018 | Details |
| A14376 | 29438686 | J Pediatr (Rio J) | Evaluation of nonalcoholic fatty liver disease using magnetic resonance in obese children and adolescents. | 2018 | Details |
| A14377 | 29438460 | Adv Nutr | Practical Dietary Recommendations for the Prevention and Management of Nonalcoholic Fatty Liver Disease in Adults. | 2018 | Details |
| A14378 | 29438418 | PLoS One | Bile acid detoxifying enzymes limit susceptibility to liver fibrosis in female SHRSP5/Dmcr rats fed with a high-fat-cholesterol diet. | 2018 | Details |
| A14379 | 29437870 | Gut | CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity. | 2018 | Details |
| A14380 | 29437160 | Int J Obes (Lond) | Protective effect of black relative to white race against non-alcoholic fatty liver disease in patients with severe obesity, independent of type 2 diabetes. | 2017 | Details |
| A14381 | 29435319 | United European Gastroenterol J | Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitis. | 2017 | Details |
| A14382 | 29434731 | Exp Ther Med | Correlation between PPAR-α methylation level in peripheral blood and inflammatory factors of NAFLD patients with DM. | 2017 | Details |
| A14383 | 29434690 | Exp Ther Med | Changes in inflammatory factors and prognosis of patients complicated with non-alcoholic fatty liver disease undergoing coronary artery bypass grafting. | 2017 | Details |
| A14384 | 29434074 | Endocr J | Validation of simple indexes for nonalcoholic fatty liver disease in western China: a retrospective cross-sectional study. | 2018 | Details |
| A14385 | 29432786 | Biochimie | Oleic acid induces the novel apolipoprotein O and reduces mitochondrial membrane potential in chicken and human hepatoma cells. | 2018 | Details |
| A14386 | 29432700 | J Int Med Res | Relationship between diverticulosis and nonalcoholic fatty liver disease in elderly patients. | 2018 | Details |
| A14387 | 29432207 | J Pediatr Endocrinol Metab | Prevalence of comorbid conditions pre-existing and diagnosed at a tertiary care pediatric weight management clinic. | 2018 | Details |
| A14388 | 29431526 | Expert Rev Gastroenterol Hepatol | The potential role of statins in treating liver disease. | 2018 | Details |
| A14390 | 29431403 | Am Fam Physician | Mildly Elevated Liver Transaminase Levels: Causes and Evaluation. | 2017 | Details |
| A14391 | 29430321 | Liver Res | Interaction between stress responses and circadian metabolism in metabolic disease. | 2017 | Details |
| A14392 | 29429624 | Cell Immunol | Macrophages and lipid metabolism. | 2018 | Details |
| A14393 | 29429367 | Arch Physiol Biochem | Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin signaling, and blocking ghrelin acylation. | 2018 | Details |
| A14394 | 29428719 | Biochem Biophys Res Commun | Combination effects of alogliptin and pioglitazone on steatosis and hepatic fibrosis formation in a mouse model of non-alcoholic steatohepatitis. | 2018 | Details |
| A14395 | 29428667 | Biomed Pharmacother | Silybum marianum oil attenuates hepatic steatosis and oxidative stress in high fat diet-fed mice. | 2018 | Details |